Crowdonomics
WatchlistPortfolio
Akttyva Therapeutics, Inc.

Reg CF · SAFE · Mar 2022

ClosedReg CFSAFE
via Fundify · last checked Aug 17, 2026
Raised
$0 / $1M max
0% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2019–FY2020 · hover for source
$0
−$4K
FY2019
$0
−$38K
FY2020
RevenueNet income
Metric
FY2019 reviewed*
FY2020 reviewed*
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$4,409
-$37,738
Taxes paid
$0
$1,148
Balance sheet
Cash
$4,423
$420,402
Accounts receivable
$0
$0
Total assets
$4,423
$420,402
Short-term debt
$555
$234,122
Long-term debt
$0
$200,000
Total liabilities
$555
$434,122
Other
Headcount
—
4

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

2 amendments
  1. Mar 11, 2022
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  2. Mar 4, 2022
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target$25,000
Max$1,000,000
Min investment—
OpenedMar 1, 2022
DeadlineJul 31, 2022
ClosedJul 31, 2022
Days active152

Links & provenance

SEC filing
Source: SEC EDGAR
0001910093-22-000003
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.